FSHB抗体 新品

+ +

•  

   

     Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);    

  
  

•  

   

     Western blot analysis using FSHB mouse mAb against Cos7 (1), HepG2 (2), HEK293 (3) cell lysate.    

  
  

•  

   

     Flow cytometric analysis of HepG2 cells using FSHB mouse mAb (green) and negative control (red).    

  
  

Follicle-stimulating hormone (FSH) is a glycoprotein critical for reproductive function, regulating gametogenesis and steroidogenesis. It comprises two subunits: α (common to gonadotropins) and β (FSHB), which confers biological specificity. FSHB antibodies target the β-subunit, disrupting FSH signaling. These antibodies are primarily studied in two contexts: research tools and clinical pathology.

In research, FSHB antibodies enable precise detection of FSH in immunoassays or tissue studies, aiding investigations into reproductive disorders, pituitary function, and hormone dynamics. They also help map FSH receptor interactions or hormone biosynthesis pathways. Clinically, autoantibodies against FSHB are rare but implicated in autoimmune hypophysitis or infertility, where they neutralize FSH bioactivity, impairing folliculogenesis in females or spermatogenesis in males. Such cases highlight FSHB's role in reproductive health and the pathological consequences of its dysregulation.

Additionally, FSHB antibodies are explored in contraceptive vaccine development, leveraging immunoneutralization to suppress fertility transiently. However, challenges include ensuring specificity and avoiding cross-reactivity with other glycoprotein hormones (e.g., TSH, LH) due to shared α-subunits. Advances in monoclonal antibody technology have improved target selectivity, enhancing both diagnostic accuracy and therapeutic potential. Overall, FSHB antibodies serve as vital tools for unraveling reproductive biology and addressing associated disorders.